Announced Fri, 25 Sept, 2026 · 16:41 IST
Emcure files Investor Presentation; FY26 PAT up 33%, margins expand
Mgmt Guided Margin ImprovementAnalyst Day Multiyear TargetsPromoter Disclosed Acquisition PlansOrder Pipeline DisclosedInvestor Communications View source PDFExplain this filing
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹1935.00
prior close
₹1935.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4+0.1-0.2-0.5+0.4-0.1-0.1+0.1-0.7-5.0————
Up moveDown movePending
AI summary
Emcure filed its September 2026 investor presentation with exchanges. FY26 revenue rose 16.6% to about INR 92,035 Mn (USD 1 Bn+), EBITDA up 21.8% to INR 17,886 Mn (margin 19.4%, up 80 bps), PAT up 33.1% to INR 9,413 Mn (margin 10.2%, up 120 bps). International grew 22.2% led by Europe at 25.5%. Q1 FY27 revenue rose 22.8% to INR 25,804 Mn; PAT up 36.2%. Outlined FY26-FY30 growth priorities and pipeline of 55 plus Europe and 50 plus Canada products.
Likely market impact
Strong FY26 print with margin gains, especially international. Reinforces growth story. No fresh surprises versus recent disclosures.